Eterobarb
From Self-sufficiency
File:Eterobarb.png | |
Systematic (IUPAC) name | |
---|---|
5-ethyl-1,3-bis(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione | |
Clinical data | |
Routes of administration | Oral |
Identifiers | |
CAS Number | 27511-99-5 |
ATC code | none |
PubChem | CID 33925 |
Chemical data | |
Formula | C16H20N2O5 |
Molar mass | 320.340 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Eterobarb (Antilon) is a barbiturate derivative. It has mainly anticonvulsant action with less sedative effects than the closely related compound phenobarbital. It saw reasonable success in clinical trials, but is not in widespread medical use.[1][2]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
- ↑ Gallagher BB, Baumel IP, Woodbury SG, Dimicco JA. Clinical evaluation of eterobarb, a new anticonvulsant drug. Neurology. 1975 May;25(5):399-404. PMID 1094318
- ↑ Smith DB, Goldstein SG, Roomet A. A comparison of the toxicity effects of the anticonvulsant eterobarb (antilon, DMMP) and phenobarbital in normal human volunteers. Epilepsia. 1986 Mar-Apr;27(2):149-55. PMID 3956454
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Barbiturates
- Ethers
- Nervous system drug stubs
- 2Fix